Author:
Vadell Haydée C.,Barroso Reinaldo L.,Dieguez Aglae C.,Pujals Adrian M.,Á. Guerra Eloy D.
Abstract
Background & Aims:
To validate a predictive model of pre-eclampsia for classifying pregnant women into pre-eclamptic and healthy groups.
Materials and Methods:
A cohort study was carried out in a total of 132 pregnant women, including biochemical and clinical parameters for assessing the classification performed by a predictive model of pre-eclampsia from a 10-fold cross-validation method and the experts’ criteria.
Results:
A highly predictive value was obtained from the set of biochemical parameters included in the proposed model. Wilks’ Lambda, eigenvalues, canonical correlation, and distances between centroids of the groups point to the high classificatory power of the discriminant function. Risk indexes, computed from the centroids, provided a measure of different risk levels for this condition. The analysis of these indexes in a prospective study allowed assessing the effect of the parameters. The new ten models obtained from a 10-fold cross-validation achieved a 100% of correct classification (AUC:1.00; CI:0.00-1.00; p=0.00). The sensitivity and specificity of the model, obtained from ROC curves, showed the consistency of the model, even though there were only four clinical manifestations of the entity. Moreover, the risk indexes were assessed from the experts’ criteria in the cohort study, showing an AUC of 100% in the 3rd trimester of pregnancy.
Conclusions:
The model and proposed pre-eclampsia risk indexes could constitute an accurate diagnostic tool, employing markers of oxidative stress as a significant element in the prediction of this entity.
Publisher
Bentham Science Publishers Ltd.
Subject
Biochemistry, medical,Clinical Biochemistry,Medicine (miscellaneous)
Reference19 articles.
1. Delgado CJ, López BR.
Extremely serious maternal morbidity from hypertensive disorders during pregnancy.
Collective of authors extremely serious maternal morbidity, a current challenge for the reduction of maternal mortality
2012;
90-116.
2. Graham J, Burton MD.
Eric Jauniaux, MD. Oxidative stress.
Best Pract Res Clin Obstet Gynaecol
2011;
25
: 287-99.
3. Carrillo ER, Sánchez ZMJ.
Molecular bases of preeclampsia-eclampsia.
Rev Invest Med
2013;
20
(2)
: 103-9.
4. Rodríguez GM, Egaña UG, Márquez AR, Bachmann MM, Soto AA.
Preeclampsia: Mediadores moleculares del daño placentario.
Rev Chil Obstet Ginecol
2012;
77
(1)
: 72-8.
5. Scazzocchio E, Figueras F, Crispi F, et al.
Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting.
Am J Obstet Gynecol
2013;
208
(3)
: 203.e1-203.e10.